Paracrine Regulation of Aldosterone Secretion in Physiological and Pathophysiological Conditions
- PMID: 30678861
- DOI: 10.1016/bs.vh.2018.10.001
Paracrine Regulation of Aldosterone Secretion in Physiological and Pathophysiological Conditions
Abstract
Aldosterone secretion by the zona glomerulosa of the adrenal cortex is controlled by circulating factors including the renin angiotensin system (RAS) and potassium. Mineralocorticoid production is also regulated through an autocrine/paracrine mechanism by a wide variety of bioactive signals released in the vicinity of adrenocortical cells by chromaffin cells, nerve endings, cells of the immune system, endothelial cells and adipocytes. These regulatory factors include conventional neurotransmitters and neuropeptides. Their physiological role in the control of aldosterone secretion is not fully understood, but it is likely that they participate in the RAS-independent regulation of zona glomerulosa cells. Interestingly, recent observations indicate that autocrine/paracrine processes are involved in the pathophysiology of primary aldosteronism. The intraadrenal regulatory systems observed in aldosterone-producing adenomas (APA), although globally similar to those occurring in the normal adrenal gland, harbor alterations at different levels, which tend to strengthen the potency of paracrine signals to activate aldosterone secretion. Enhancement of paracrine stimulatory tone may participate to APA expansion and aldosterone hypersecretion together with somatic mutations of driver genes which activate the calcium signaling pathway and subsequently aldosterone synthase expression. Intraadrenal regulatory mechanisms represent thus promising pharmacological targets for the treatment of primary aldosteronism.
Keywords: Adrenal; Mast cell; Mutations; Paracrine communication; Primary aldosteronism; Serotonin; Steroidogenesis.
© 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism.Eur J Endocrinol. 2013 Oct 4;169(5):R115-38. doi: 10.1530/EJE-13-0308. Print 2013 Nov. Eur J Endocrinol. 2013. PMID: 23956298 Review.
-
Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms.Mol Cell Endocrinol. 2015 Jun 15;408:198-204. doi: 10.1016/j.mce.2014.11.013. Epub 2014 Nov 26. Mol Cell Endocrinol. 2015. PMID: 25433205 Review.
-
Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):E4591-9. doi: 10.1073/pnas.1505529112. Epub 2015 Aug 3. Proc Natl Acad Sci U S A. 2015. PMID: 26240369 Free PMC article.
-
Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).Int J Mol Med. 2005 Jan;15(1):3-13. Int J Mol Med. 2005. PMID: 15583821 Review.
-
Role of ACTH in the Interactive/Paracrine Regulation of Adrenal Steroid Secretion in Physiological and Pathophysiological Conditions.Front Endocrinol (Lausanne). 2016 Jul 20;7:98. doi: 10.3389/fendo.2016.00098. eCollection 2016. Front Endocrinol (Lausanne). 2016. PMID: 27489549 Free PMC article. Review.
Cited by
-
Sexual Dimorphism of Corticosteroid Signaling during Kidney Development.Int J Mol Sci. 2021 May 18;22(10):5275. doi: 10.3390/ijms22105275. Int J Mol Sci. 2021. PMID: 34069759 Free PMC article. Review.
-
Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats.Lab Anim Res. 2023 Apr 14;39(1):7. doi: 10.1186/s42826-023-00159-2. Lab Anim Res. 2023. PMID: 37055870 Free PMC article.
-
G protein-coupled estrogen receptor: a promising therapeutic target for aldosterone-induced hypertension.Front Endocrinol (Lausanne). 2023 Aug 17;14:1226458. doi: 10.3389/fendo.2023.1226458. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37664844 Free PMC article. Review.
-
Vascular and hormonal interactions in the adrenal gland.Front Endocrinol (Lausanne). 2022 Nov 24;13:995228. doi: 10.3389/fendo.2022.995228. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36506065 Free PMC article. Review.
-
Prevalence of an angiotensin-converting enzyme gene variant in dogs.Canine Med Genet. 2021 Jul 13;8(1):6. doi: 10.1186/s40575-021-00105-2. Canine Med Genet. 2021. PMID: 34256860 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources